Furthermore, benfotiamine has been shown to suppress NF-κB-mediated inflammation and stabilize mitochondrial integrity [50], supporting its potential as a therapeutic agent in neurodegenerative and stress-related disorders by maintaining redox homeostasis and protecting against oxidative stress. The gene discussed is NFKB1; the disease is stress-related disorder.